
Tammy Worth
Writer and Editor at Freelance
Contributing Writer at Leader's Edge Magazine
Articles
-
2 weeks ago |
nature.com | Tammy Worth
A healthy diet and regular exercise have long been staples of weight management. But research shows that the role of sleep, which helps to regulate appetite hormones and calorie intake, is just as important. Esra Tasali, a sleep specialist at University of Chicago Medicine in Illinois and director of the UChicago Sleep Center, spoke to Nature about why getting sufficient sleep could be crucial to weight loss and maintenance. How did you end up studying sleep and weight loss?
-
2 weeks ago |
nature.com | Tammy Worth
When neurobiologist Dragana Rogulja began studying sleep in her laboratory at Harvard Medical School in Boston, Massachusetts, in 2013, she had no idea what her experiments would tell her about how sleep affects the body. She wasn’t assuming — as many people do — that it’s a function mainly of the brain.
-
3 weeks ago |
leadersedge.com | Tammy Worth |Zach Ewell
Health+Benefits Vital Signs the April 2025 issue Q You began working on loneliness before COVID, so this isn’t a new problem. What made you delve into this space initially? A I started focusing on loneliness because in the early 20-teens it became very clear that there were significant health consequences from loneliness. And they went beyond just the mental health ones you might think of. We were seeing research that loneliness could increase the risk of early mortality.
-
1 month ago |
nature.com | Tammy Worth
In October, after almost a decade of work, Google licensed its artificial intelligence (AI) model for detecting the eye disease diabetic retinopathy to three health-care technology companies — two in India and one in Thailand. It came with a condition: the firms have to provide six million free AI screenings to people in low- and middle-income countries (LMICs) over the next ten years.
-
1 month ago |
leadersedge.com | Tammy Worth |Zach West
Health+Benefits Vital Signs the March 2025 issue The Inflation Reduction Act of 2022 authorized the Centers for Medicare and Medicaid Services (CMS) to work with pharmaceutical manufacturers to set prices on 10 drugs for diabetes, arthritis, and other conditions for almost nine million Medicare Part D beneficiaries beginning in 2026. Further negotiations on additional drugs are planned. Gremminger discusses what, if any, impact this will have on the private insurance market.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 84
- Tweets
- 35
- DMs Open
- No

https://t.co/IXCoDpkKBU

Sign outside the Chicago Bagel Authority on Belmont Avenue: https://t.co/rUE49UGd2P

Al Gore met with Trump today on climate change. The planet may be warming but hell just froze over... https://t.co/bTMYYEmij1

My recent piece on ed battle in B.S.-- Blue Springs is Latest Battleground For Education Program https://t.co/uSBLEIqBz0 via @flatlandKC